MENU
+Compare
NVCR
Stock ticker: NASDAQ
AS OF
Jun 11 closing price
Price
$17.36
Change
-$1.02 (-5.55%)
Capitalization
1.66B

NVCR NovoCure Limited Forecast, Technical & Fundamental Analysis

NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more

NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVCR with price predictions
Jun 10, 2025

NVCR in upward trend: price rose above 50-day moving average on June 10, 2025

NVCR moved above its 50-day moving average on June 10, 2025 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where NVCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for NVCR crossed bullishly above the 50-day moving average on May 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVCR advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 157 cases where NVCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVCR as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVCR turned negative on June 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVCR broke above its upper Bollinger Band on May 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.577) is normal, around the industry mean (24.397). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.235) is also within normal values, averaging (42.944).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVCR is expected to report earnings to rise 23.23% to -38 cents per share on July 24

NovoCure Limited NVCR Stock Earnings Reports
Q2'25
Est.
$-0.38
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.25
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.09
The last earnings report on April 24 showed earnings per share of -31 cents, beating the estimate of -49 cents. With 2.12M shares outstanding, the current market capitalization sits at 1.66B.
A.I. Advisor
published General Information

General Information

a commercial-stage oncology company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPYCX9.390.03
+0.32%
Touchstone Sands Capital Intl Gr Eq C
RWIEX68.820.14
+0.20%
American Funds Capital World Gr&Inc R4
LICRX16.79N/A
N/A
Lord Abbett International Equity R3
FGSCX27.17N/A
N/A
Federated Hermes MDT Mid Cap Growth C
ABCIX22.23N/A
N/A
American Beacon The London Co Inc Eq R5

NVCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+8.76%
RVTY - NVCR
42%
Loosely correlated
+3.63%
AZTA - NVCR
40%
Loosely correlated
+3.89%
TWST - NVCR
39%
Loosely correlated
+3.27%
A - NVCR
39%
Loosely correlated
+3.24%
MTD - NVCR
38%
Loosely correlated
+1.77%
More